Jubilant Pharmova Limited has intimated the stock exchanges about upcoming investor and analyst meetings pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The management of the company will physically meet with institutional investors in Mumbai from August 13, 2026 to August 14, 2026. The meetings will be conducted in both one-on-one and group formats.
The meetings are organized by Emkay Global Financial Services as part of their Flagship Conference called 'Emkay Confluence'. The schedule is subject to change due to exigencies on the part of investors, analysts, or the company.
Participating Institutions
The following eight institutional investors are scheduled to attend:
- HDFC AMC
- ICICI Prudential AMC
- Karma Capital
- Motilal Oswal AMC
- ICICI Prudential Life Insurance
- ITI Mutual Fund
- Tata Asset Management
- MK Ventures
Discussion Topics
During the meetings, the management will discuss the Q1 FY27 earnings presentation. The company will file this presentation on August 10, 2026, following the disclosure of Q1 FY27 financial results.